Click for best price
Pulmonary Drug Delivery Devices Market Size, Share 2022
Market Analysis and Insights: Global Pulmonary Drug Delivery Devices Market
The global Pulmonary Drug Delivery Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pulmonary Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pulmonary Drug Delivery Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pulmonary Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pulmonary Drug Delivery Devices market.
Global Pulmonary Drug Delivery Devices Scope and Market Size
Pulmonary Drug Delivery Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pulmonary Drug Delivery Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Segment by Application
Asthma
COPD
Cystic Fibrosis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Pulmonary Drug Delivery Devices product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Pulmonary Drug Delivery Devices, with price, sales, revenue, and global market share of Pulmonary Drug Delivery Devices from 2019 to 2022.
Chapter 3, the Pulmonary Drug Delivery Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pulmonary Drug Delivery Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pulmonary Drug Delivery Devices.
Chapter 13, 14, and 15, to describe Pulmonary Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Pulmonary Drug Delivery Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Pulmonary Drug Delivery Devices Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
120 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Pulmonary Drug Delivery Devices Product Introduction
1.2 Global Pulmonary Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pulmonary Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pulmonary Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.3 United States Pulmonary Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pulmonary Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pulmonary Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.4 Pulmonary Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pulmonary Drug Delivery Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pulmonary Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pulmonary Drug Delivery Devices Market Dynamics
1.5.1 Pulmonary Drug Delivery Devices Industry Trends
1.5.2 Pulmonary Drug Delivery Devices Market Drivers
1.5.3 Pulmonary Drug Delivery Devices Market Challenges
1.5.4 Pulmonary Drug Delivery Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pulmonary Drug Delivery Devices Market Segment by Type
2.1.1 Dry Powder Inhaler
2.1.2 Metered Dose Inhaler
2.1.3 Nebulizer
2.2 Global Pulmonary Drug Delivery Devices Market Size by Type
2.2.1 Global Pulmonary Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pulmonary Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pulmonary Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pulmonary Drug Delivery Devices Market Size by Type
2.3.1 United States Pulmonary Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pulmonary Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pulmonary Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pulmonary Drug Delivery Devices Market Segment by Application
3.1.1 Asthma
3.1.2 COPD
3.1.3 Cystic Fibrosis
3.1.4 Other
3.2 Global Pulmonary Drug Delivery Devices Market Size by Application
3.2.1 Global Pulmonary Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pulmonary Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pulmonary Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pulmonary Drug Delivery Devices Market Size by Application
3.3.1 United States Pulmonary Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pulmonary Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pulmonary Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pulmonary Drug Delivery Devices Competitor Landscape by Company
4.1 Global Pulmonary Drug Delivery Devices Market Size by Company
4.1.1 Top Global Pulmonary Drug Delivery Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Pulmonary Drug Delivery Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Pulmonary Drug Delivery Devices Price by Manufacturer (2017-2022)
4.2 Global Pulmonary Drug Delivery Devices Concentration Ratio (CR)
4.2.1 Pulmonary Drug Delivery Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pulmonary Drug Delivery Devices in 2021
4.2.3 Global Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pulmonary Drug Delivery Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pulmonary Drug Delivery Devices Product Type
4.3.3 Date of International Manufacturers Enter into Pulmonary Drug Delivery Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pulmonary Drug Delivery Devices Market Size by Company
4.5.1 Top Pulmonary Drug Delivery Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pulmonary Drug Delivery Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pulmonary Drug Delivery Devices Sales by Players (2020, 2021 & 2022)
5 Global Pulmonary Drug Delivery Devices Market Size by Region
5.1 Global Pulmonary Drug Delivery Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pulmonary Drug Delivery Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Pulmonary Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pulmonary Drug Delivery Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Pulmonary Drug Delivery Devices Sales in Value by Region: 2017-2022
5.3.2 Global Pulmonary Drug Delivery Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pulmonary Drug Delivery Devices Market Size YoY Growth 2017-2028
6.1.2 North America Pulmonary Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pulmonary Drug Delivery Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pulmonary Drug Delivery Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pulmonary Drug Delivery Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Pulmonary Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pulmonary Drug Delivery Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Pulmonary Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pulmonary Drug Delivery Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pulmonary Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Corporation Information
7.1.2 Boehringer Ingelheim GmbH Description and Business Overview
7.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Products Offered
7.1.5 Boehringer Ingelheim GmbH Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Corporation Information
7.2.2 Novartis AG Description and Business Overview
7.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis AG Pulmonary Drug Delivery Devices Products Offered
7.2.5 Novartis AG Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporation Information
7.3.2 GlaxoSmithKline Description and Business Overview
7.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Products Offered
7.3.5 GlaxoSmithKline Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Corporation Information
7.4.2 AstraZeneca Description and Business Overview
7.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 AstraZeneca Pulmonary Drug Delivery Devices Products Offered
7.4.5 AstraZeneca Recent Development
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Corporation Information
7.5.2 Teva Pharmaceutical Industries Description and Business Overview
7.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Products Offered
7.5.5 Teva Pharmaceutical Industries Recent Development
7.6 Merck
7.6.1 Merck Corporation Information
7.6.2 Merck Description and Business Overview
7.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Merck Pulmonary Drug Delivery Devices Products Offered
7.6.5 Merck Recent Development
7.7 MannKind
7.7.1 MannKind Corporation Information
7.7.2 MannKind Description and Business Overview
7.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 MannKind Pulmonary Drug Delivery Devices Products Offered
7.7.5 MannKind Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Mylan N.V
7.9.1 Mylan N.V Corporation Information
7.9.2 Mylan N.V Description and Business Overview
7.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Mylan N.V Pulmonary Drug Delivery Devices Products Offered
7.9.5 Mylan N.V Recent Development
7.10 Omron Corp
7.10.1 Omron Corp Corporation Information
7.10.2 Omron Corp Description and Business Overview
7.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Omron Corp Pulmonary Drug Delivery Devices Products Offered
7.10.5 Omron Corp Recent Development
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Corporation Information
7.11.2 F. Hoffmann-La Roche Description and Business Overview
7.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Products Offered
7.11.5 F. Hoffmann-La Roche Recent Development
7.12 3M Healthcare
7.12.1 3M Healthcare Corporation Information
7.12.2 3M Healthcare Description and Business Overview
7.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 3M Healthcare Products Offered
7.12.5 3M Healthcare Recent Development
7.13 Sunovion Pharmaceuticals
7.13.1 Sunovion Pharmaceuticals Corporation Information
7.13.2 Sunovion Pharmaceuticals Description and Business Overview
7.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Sunovion Pharmaceuticals Products Offered
7.13.5 Sunovion Pharmaceuticals Recent Development
7.14 Koninklijke Philips N.V
7.14.1 Koninklijke Philips N.V Corporation Information
7.14.2 Koninklijke Philips N.V Description and Business Overview
7.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Koninklijke Philips N.V Products Offered
7.14.5 Koninklijke Philips N.V Recent Development
7.15 Gerresheimer AG
7.15.1 Gerresheimer AG Corporation Information
7.15.2 Gerresheimer AG Description and Business Overview
7.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Gerresheimer AG Products Offered
7.15.5 Gerresheimer AG Recent Development
7.16 Bespak
7.16.1 Bespak Corporation Information
7.16.2 Bespak Description and Business Overview
7.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Bespak Products Offered
7.16.5 Bespak Recent Development
7.17 AptarGroup
7.17.1 AptarGroup Corporation Information
7.17.2 AptarGroup Description and Business Overview
7.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.17.4 AptarGroup Products Offered
7.17.5 AptarGroup Recent Development
7.18 SHL Group
7.18.1 SHL Group Corporation Information
7.18.2 SHL Group Description and Business Overview
7.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.18.4 SHL Group Products Offered
7.18.5 SHL Group Recent Development
7.19 Nypro Healthcare
7.19.1 Nypro Healthcare Corporation Information
7.19.2 Nypro Healthcare Description and Business Overview
7.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Nypro Healthcare Products Offered
7.19.5 Nypro Healthcare Recent Development
7.20 Hovione
7.20.1 Hovione Corporation Information
7.20.2 Hovione Description and Business Overview
7.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Hovione Products Offered
7.20.5 Hovione Recent Development
7.21 Chiesi Farmaceutici S.P.A
7.21.1 Chiesi Farmaceutici S.P.A Corporation Information
7.21.2 Chiesi Farmaceutici S.P.A Description and Business Overview
7.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Chiesi Farmaceutici S.P.A Products Offered
7.21.5 Chiesi Farmaceutici S.P.A Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pulmonary Drug Delivery Devices Industry Chain Analysis
8.2 Pulmonary Drug Delivery Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pulmonary Drug Delivery Devices Distributors
8.3 Pulmonary Drug Delivery Devices Production Mode & Process
8.4 Pulmonary Drug Delivery Devices Sales and Marketing
8.4.1 Pulmonary Drug Delivery Devices Sales Channels
8.4.2 Pulmonary Drug Delivery Devices Distributors
8.5 Pulmonary Drug Delivery Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pulmonary Drug Delivery Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pulmonary Drug Delivery Devices Market Trends
Table 3. Pulmonary Drug Delivery Devices Market Drivers
Table 4. Pulmonary Drug Delivery Devices Market Challenges
Table 5. Pulmonary Drug Delivery Devices Market Restraints
Table 6. Global Pulmonary Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pulmonary Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pulmonary Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pulmonary Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pulmonary Drug Delivery Devices Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pulmonary Drug Delivery Devices Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pulmonary Drug Delivery Devices Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pulmonary Drug Delivery Devices Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Pulmonary Drug Delivery Devices Sales Share by Manufacturer, 2017-2022
Table 15. Global Pulmonary Drug Delivery Devices Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Pulmonary Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pulmonary Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices as of 2021)
Table 18. Top Players of Pulmonary Drug Delivery Devices in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pulmonary Drug Delivery Devices Product Type
Table 20. Date of International Manufacturers Enter into Pulmonary Drug Delivery Devices Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pulmonary Drug Delivery Devices Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pulmonary Drug Delivery Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pulmonary Drug Delivery Devices Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pulmonary Drug Delivery Devices Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Pulmonary Drug Delivery Devices Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pulmonary Drug Delivery Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pulmonary Drug Delivery Devices Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Pulmonary Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Pulmonary Drug Delivery Devices Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pulmonary Drug Delivery Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Pulmonary Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pulmonary Drug Delivery Devices Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Pulmonary Drug Delivery Devices Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Pulmonary Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Pulmonary Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Pulmonary Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Boehringer Ingelheim GmbH Corporation Information
Table 43. Boehringer Ingelheim GmbH Description and Business Overview
Table 44. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product
Table 46. Boehringer Ingelheim GmbH Recent Development
Table 47. Novartis AG Corporation Information
Table 48. Novartis AG Description and Business Overview
Table 49. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis AG Product
Table 51. Novartis AG Recent Development
Table 52. GlaxoSmithKline Corporation Information
Table 53. GlaxoSmithKline Description and Business Overview
Table 54. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. GlaxoSmithKline Product
Table 56. GlaxoSmithKline Recent Development
Table 57. AstraZeneca Corporation Information
Table 58. AstraZeneca Description and Business Overview
Table 59. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. AstraZeneca Product
Table 61. AstraZeneca Recent Development
Table 62. Teva Pharmaceutical Industries Corporation Information
Table 63. Teva Pharmaceutical Industries Description and Business Overview
Table 64. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Teva Pharmaceutical Industries Product
Table 66. Teva Pharmaceutical Industries Recent Development
Table 67. Merck Corporation Information
Table 68. Merck Description and Business Overview
Table 69. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Merck Product
Table 71. Merck Recent Development
Table 72. MannKind Corporation Information
Table 73. MannKind Description and Business Overview
Table 74. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. MannKind Product
Table 76. MannKind Recent Development
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Business Overview
Table 79. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bristol-Myers Squibb Product
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Mylan N.V Corporation Information
Table 83. Mylan N.V Description and Business Overview
Table 84. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Mylan N.V Product
Table 86. Mylan N.V Recent Development
Table 87. Omron Corp Corporation Information
Table 88. Omron Corp Description and Business Overview
Table 89. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Omron Corp Product
Table 91. Omron Corp Recent Development
Table 92. F. Hoffmann-La Roche Corporation Information
Table 93. F. Hoffmann-La Roche Description and Business Overview
Table 94. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. F. Hoffmann-La Roche Product
Table 96. F. Hoffmann-La Roche Recent Development
Table 97. 3M Healthcare Corporation Information
Table 98. 3M Healthcare Description and Business Overview
Table 99. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. 3M Healthcare Product
Table 101. 3M Healthcare Recent Development
Table 102. Sunovion Pharmaceuticals Corporation Information
Table 103. Sunovion Pharmaceuticals Description and Business Overview
Table 104. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Sunovion Pharmaceuticals Product
Table 106. Sunovion Pharmaceuticals Recent Development
Table 107. Koninklijke Philips N.V Corporation Information
Table 108. Koninklijke Philips N.V Description and Business Overview
Table 109. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Koninklijke Philips N.V Product
Table 111. Koninklijke Philips N.V Recent Development
Table 112. Gerresheimer AG Corporation Information
Table 113. Gerresheimer AG Description and Business Overview
Table 114. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Gerresheimer AG Product
Table 116. Gerresheimer AG Recent Development
Table 117. Bespak Corporation Information
Table 118. Bespak Description and Business Overview
Table 119. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Bespak Product
Table 121. Bespak Recent Development
Table 122. AptarGroup Corporation Information
Table 123. AptarGroup Description and Business Overview
Table 124. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. AptarGroup Product
Table 126. AptarGroup Recent Development
Table 127. SHL Group Corporation Information
Table 128. SHL Group Description and Business Overview
Table 129. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. SHL Group Product
Table 131. SHL Group Recent Development
Table 132. Nypro Healthcare Corporation Information
Table 133. Nypro Healthcare Description and Business Overview
Table 134. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Nypro Healthcare Product
Table 136. Nypro Healthcare Recent Development
Table 137. Hovione Corporation Information
Table 138. Hovione Description and Business Overview
Table 139. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Hovione Product
Table 141. Hovione Recent Development
Table 142. Chiesi Farmaceutici S.P.A Corporation Information
Table 143. Chiesi Farmaceutici S.P.A Description and Business Overview
Table 144. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Chiesi Farmaceutici S.P.A Product
Table 146. Chiesi Farmaceutici S.P.A Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Pulmonary Drug Delivery Devices Customers List
Table 150. Pulmonary Drug Delivery Devices Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Drug Delivery Devices Product Picture
Figure 2. Global Pulmonary Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pulmonary Drug Delivery Devices Market Size 2017-2028 (US$ Million)
Figure 4. Global Pulmonary Drug Delivery Devices Sales 2017-2028 (K Units)
Figure 5. United States Pulmonary Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pulmonary Drug Delivery Devices Market Size 2017-2028 (US$ Million)
Figure 7. United States Pulmonary Drug Delivery Devices Sales 2017-2028 (K Units)
Figure 8. United States Pulmonary Drug Delivery Devices Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pulmonary Drug Delivery Devices Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Pulmonary Drug Delivery Devices Report Years Considered
Figure 11. Product Picture of Dry Powder Inhaler
Figure 12. Product Picture of Metered Dose Inhaler
Figure 13. Product Picture of Nebulizer
Figure 14. Global Pulmonary Drug Delivery Devices Market Share by Type in 2022 & 2028
Figure 15. Global Pulmonary Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Pulmonary Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
Figure 18. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Pulmonary Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Pulmonary Drug Delivery Devices Market Share by Type in 2022 & 2028
Figure 21. United States Pulmonary Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Pulmonary Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
Figure 24. United States Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Pulmonary Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Asthma
Figure 27. Product Picture of COPD
Figure 28. Product Picture of Cystic Fibrosis
Figure 29. Product Picture of Other
Figure 30. Global Pulmonary Drug Delivery Devices Market Share by Application in 2022 & 2028
Figure 31. Global Pulmonary Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Pulmonary Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
Figure 34. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Pulmonary Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Pulmonary Drug Delivery Devices Market Share by Application in 2022 & 2028
Figure 37. United States Pulmonary Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Pulmonary Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
Figure 40. United States Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Pulmonary Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Pulmonary Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Pulmonary Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Pulmonary Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Pulmonary Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Pulmonary Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Pulmonary Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Pulmonary Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Pulmonary Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Pulmonary Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Pulmonary Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE Pulmonary Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Pulmonary Drug Delivery Devices Value Chain
Figure 76. Pulmonary Drug Delivery Devices Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
